Evidence map›Paper›PMID 36417534›Full record

ArticleScience advances2022

Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism.

Scott Yeudall, Clint M Upchurch, Philip V Seegren, Caitlin M Pavelec, Jan Greulich, Michael C Lemke, Thurl E Harris, Bimal N Desai, Kyle L Hoehn, Norbert Leitinger

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. ZXDB Drives Macrophage Inflammatory Programming in Sepsis-Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  10. Article
  11. ReducediScience · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Scott YeudallDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0002-5417-7157
Clint M UpchurchDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0001-8300-3394
Philip V SeegrenDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0002-7153-4670
Caitlin M PavelecDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Jan GreulichEnvironmentally-Induced Cardiovascular Degeneration, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital and Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Michael C LemkeDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0002-2351-9206
Thurl E HarrisDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0003-1742-6043
Bimal N DesaiDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0002-3928-5854
Kyle L HoehnDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Norbert LeitingerDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0001-6224-5175
University of Virginia · USDüsseldorf University Hospital · DEUNSW Sydney · AU

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A. · 2014 to 2023
$24.0M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
TRPM7 at the Crossroads of Tissue Homeostasis and inflammationR01GM108989 · NIGMS · UNIVERSITY OF VIRGINIA · PI DESAI, BIMAL N. · 2016 to 2024
$3.3M
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesisR01HL136314 · NHLBI · UNIVERSITY OF VIRGINIA · PI OWENS, GARY K · 2018 to 2021
$3.0M
Mitochondrial Calcium Signaling in Cell Intrinsic ImmunityR01AI155808 · NIAID · UNIVERSITY OF VIRGINIA · PI DESAI, BIMAL N. · 2021 to 2025
$2.8M
Regulation of lipin phosphatidic acid phosphatase activityR01GM136900 · NIGMS · UNIVERSITY OF VIRGINIA · PI HARRIS, THURL E. · 2020 to 2023
$1.4M
ACC enzymes and protein acetylationR01DK101803 · NIDDK · UNIVERSITY OF VIRGINIA · PI HOEHN, KYLE LEE · 2014 to 2017
$1.4M
Macrophage and Monocyte Metabolic Adaptation in Hemolysis and Sickle Cell DiseaseF30HL154554 · NHLBI · UNIVERSITY OF VIRGINIA · PI YEUDALL, SCOTT · 2021 to 2022
$87k
NHLBI NIH HHS F30 HL154554NHLBI NIH HHS P01 HL120840NHLBI NIH HHS R01 HL136314NHLBI NIH HHS T32 HL007284NIAID NIH HHS R01 AI155808NIAID NIH HHS T32 AI007163NIDDK NIH HHS R01 DK101803NIGMS NIH HHS R01 GM108989NIGMS NIH HHS R01 GM136900NIGMS NIH HHS T32 GM007055NIGMS NIH HHS T32 GM007267
6 · The paper itself

Abstract

Acetyl-CoA carboxylase (ACC) regulates lipid synthesis; however, its role in inflammatory regulation in macrophages remains unclear. We generated mice that are deficient in both ACC isoforms in myeloid cells. ACC deficiency altered the lipidomic, transcriptomic, and bioenergetic profile of bone marrow-derived macrophages, resulting in a blunted response to proinflammatory stimulation. In response to lipopolysaccharide (LPS), ACC is required for the early metabolic switch to glycolysis and remodeling of the macrophage lipidome. ACC deficiency also resulted in impaired macrophage innate immune functions, including bacterial clearance. Myeloid-specific deletion or pharmacological inhibition of ACC in mice attenuated LPS-induced expression of proinflammatory cytokines interleukin-6 (IL-6) and IL-1β, while pharmacological inhibition of ACC increased susceptibility to bacterial peritonitis in wild-type mice. Together, we identify a critical role for ACC in metabolic regulation of the innate immune response in macrophages, and thus a clinically relevant, unexpected consequence of pharmacological ACC inhibition.

Indexed as

Acetyl-CoA CarboxylaseGlucoseAnimalsInflammationLipid MetabolismLipid Metabolism, Inborn ErrorsLipopolysaccharidesMacrophagesMiceMice, KnockoutAcetyl-CoA CarboxylaseGlucoseLipopolysaccharides

Identifiers

PMID36417534
PMCPMC9683712
OpenAlexW4310088498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.